StockData
Pulmatrix, Inc. logo

Pulmatrix, Inc. (PULM) shareholders

PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.37+0.04 (+3.01%)

Close on Nov 17, 2026Market cap $5.00MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
9.2%
0M of 4M shares
Institutional holders
15
2 new, 2 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
RCM Eos PIPE HOLDINGS, LLC
Joint filing with Slawin Kevin M. (9.99%), Rapha Capital Management, LLC (9.99%)
405,3589.99%13D (active)Apr 16, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of PULMValueChange% of portfolio
Renaissance Technologies LLC122,6983.36%$208.59K+13,5500.00%
BlackRock, Inc.54,8991.50%$93.33K–0.00%
Geode Capital Management, LLC33,2990.91%$56.63K−11,3300.00%
Vanguard Capital Management LLC32,2940.88%$54.90K−1,3000.00%
SBI Securities Co., Ltd.31,2850.86%$53.19K+1,2000.00%
Shay Capital LLC18,8570.52%$32.06KNew0.00%
Vanguard Fiduciary Trust Co14,7150.40%$25.02K–0.00%
State Street Corp13,9450.38%$23.71K–0.00%
XTX Topco Ltd11,9910.33%$20.39K−1,6780.00%
UBS Group AG5150.01%$875+4920.00%
Barclays PLC150.00%$26New0.00%
Farther Finance Advisors, LLC70.00%$12–0.00%
Royal Bank of Canada70.00%$0–0.00%
Allworth Financial LP30.00%$6–0.00%
Northwestern Mutual Wealth Management Co10.00%$2–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026150M9.2%2 / 33 / 20M0M
Q1 2026150M9.0%5 / 24 / 40M0M
Q4 2025150M9.8%3 / 16 / 20M0M
Q3 2025140M9.5%4 / 34 / 20M0M
Q2 2025120M9.2%2 / 71 / 10M0M
Q1 2025110M8.6%1 / 43 / 10M0M
Q4 2024110M8.9%2 / 23 / 30M0M
Q3 2024120M7.2%3 / 33 / 10M0M
Q2 2024110M6.9%2 / 23 / 40M0M
Q1 2024130M6.8%2 / 33 / 10M0M
Q4 2023120M8.3%0 / 62 / 00M0M
Q3 2023120M10.5%0 / 71 / 20M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

10 funds held PULM in Q1 2026, 52% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of PULMValue% of fundAs of
Vanguard Extended Market Index Fund32,2940.88%$54.90K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund23,0140.63%$31.99K0.00%May 31, 2026
Fidelity Series Total Market Index Fund5,2280.14%$7.27K0.00%May 31, 2026
Fidelity Nasdaq Composite Index Fund4,5700.13%$6.35K0.00%May 31, 2026
Fidelity Total Market Index Fund4,4270.12%$6.15K0.00%May 31, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Polaris Venture Management Co. V, L.L.C.
10% owner
Apr 3, 2018Buy+15,007––67,729
Polaris Venture Management Co. V, L.L.C.
10% owner
Apr 3, 2018Buy+769,989––3,468,190
Polaris Venture Management Co. V, L.L.C.
10% owner
Apr 3, 2018Buy+6,478––29,178
Polaris Venture Management Co. V, L.L.C.
10% owner
Apr 3, 2018Buy+7,700––34,587
Polaris Venture Management Co. V, L.L.C.
10% owner
Apr 3, 2018Buy+345,551––1,556,676
Polaris Venture Management Co. V, L.L.C.
10% owner
Apr 3, 2018Buy+5,275––23,875
Matthew L. Sherman
Director
Apr 3, 2018Buy+20,000––20,000
ARCH Venture Partners VII, L.P.
–
Apr 3, 2018Buy+1,150,000––3,436,456
Mark T. Iwicki
Director
Apr 3, 2018Buy+307,000––307,000
David L. Hava
Chief Scientific Officer
Mar 22, 2017Option exercise+2,263$2.21$5.00K2,263
Robert W. Clarke
Chief Executive Officer, Director
Mar 22, 2017Option exercise+4,525$2.21$10.00K4,525
Oculus Innovative Sciences, Inc.
10% owner
Jun 17, 2015Sale−922,500$2.75$2.54M0
Oculus Innovative Sciences, Inc.
10% owner
Jun 16, 2015Sale−727,500$2.75$2.00M922,500
David Maki
Director
Jun 16, 2015Buy+36,375$6.88$250.26K218,194
David Maki
Director
Jun 16, 2015Buy+36,375$6.88$250.26K218,194
Scott M. Rocklage
Director
Jun 16, 2015Buy+33,990$6.88$233.85K1,192,154
Scott M. Rocklage
Director
Jun 16, 2015Buy+4,815$6.88$33.13K168,873
Keith Crandell
10% owner
Jun 16, 2015Buy+72,750$6.88$500.52K2,286,456
Polaris Venture Partners V, L.P.
10% owner
Jun 15, 2015Buy+1,392$6.88$9.58K52,722
Polaris Venture Partners V, L.P.
10% owner
Jun 15, 2015Buy+715$6.88$4.92K26,887
Polaris Venture Partners V, L.P.
10% owner
Jun 15, 2015Buy+490$6.88$3.37K18,600
Polaris Venture Partners V, L.P.
10% owner
Jun 15, 2015Buy+71,439$6.88$491.50K2,698,201
David L. Hava
Chief Scientific Officer
Jun 15, 2015Award+4,863––4,863
David Maki
Director
Jun 15, 2015Award+181,819––181,819
David Maki
Director
Jun 15, 2015Award+181,819––181,819
Venture Partners Iv Lp Polaris
10% owner
Jun 15, 2015Award+1,179,066––1,179,066
Venture Partners Iv Lp Polaris
10% owner
Jun 15, 2015Buy+32,059$6.88$220.57K1,211,125
Venture Partners Iv Lp Polaris
10% owner
Jun 15, 2015Buy+489$6.88$3.36K18,599
Venture Partners Iv Lp Polaris
10% owner
Jun 15, 2015Award+26,172––26,172
Venture Partners Iv Lp Polaris
10% owner
Jun 15, 2015Buy+1,392$6.88$9.58K52,692
Venture Partners Iv Lp Polaris
10% owner
Jun 15, 2015Award+18,110––18,110
Venture Partners Iv Lp Polaris
10% owner
Jun 15, 2015Buy+71,438$6.88$491.49K2,698,200
Venture Partners Iv Lp Polaris
10% owner
Jun 15, 2015Award+2,626,762––2,626,762
Venture Partners Iv Lp Polaris
10% owner
Jun 15, 2015Buy+601$6.88$4.13K22,700
Venture Partners Iv Lp Polaris
10% owner
Jun 15, 2015Award+22,099––22,099
Venture Partners Iv Lp Polaris
10% owner
Jun 15, 2015Buy+714$6.88$4.91K26,886
Venture Partners Iv Lp Polaris
10% owner
Jun 15, 2015Award+51,330––51,330
Robert W. Clarke
Chief Executive Officer, Director
Jun 15, 2015Award+18,667––18,667
Scott M. Rocklage
Director
Jun 15, 2015Award+164,058––164,058
Scott M. Rocklage
Director
Jun 15, 2015Award+1,158,164––1,158,164
Keith Crandell
10% owner
Jun 15, 2015Award+2,213,706––2,213,706
Oculus Innovative Sciences, Inc.
10% owner
Mar 23, 2015Sale−350,000$2.75$962.50K1,650,000
Gregory M. French
Director
May 11, 2014Award+58,000––58,000
Richard K. Conley
Director
May 11, 2014Award+58,000––58,000
Hojabr Alimi
CEO and Chief Science Officer, Director
May 11, 2014Award+125,000––125,000
Sameer Harish
Chief Financial Officer
May 11, 2014Award+74,600––74,600

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
1.22%
0M shares short
Days to cover
1.3
At 0M shares a day
Change since last report
-8.5%
From 0M shares
Short volume, 20 days
40.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Pulmatrix's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

See a number that looks wrong?